C. Wee, Jin Ho Kim, H. Kim, Hyun-Cheol Kang, S. Suh, B. Shin, E. Ma, I. Kim
{"title":"Psammaplin a修饰的新型放射增敏剂用于人肺癌和胶质母细胞瘤细胞","authors":"C. Wee, Jin Ho Kim, H. Kim, Hyun-Cheol Kang, S. Suh, B. Shin, E. Ma, I. Kim","doi":"10.14407/JRPR.2019.44.1.15","DOIUrl":null,"url":null,"abstract":"1Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, Korea; 2Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea; 3Institute of Radiation Medicine, Seoul National University College of Medicine, Seoul, Korea; 4School of Pharmacy, Sungkyunkwan University, Suwon, Korea; 5College of Pharmacy, Daegu Catholic University, Gyeongsan, Korea","PeriodicalId":36088,"journal":{"name":"Journal of Radiation Protection and Research","volume":"56 1","pages":""},"PeriodicalIF":0.6000,"publicationDate":"2019-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":"{\"title\":\"Psammaplin A-Modified Novel Radiosensitizers for Human Lung Cancer and Glioblastoma Cells\",\"authors\":\"C. Wee, Jin Ho Kim, H. Kim, Hyun-Cheol Kang, S. Suh, B. Shin, E. Ma, I. Kim\",\"doi\":\"10.14407/JRPR.2019.44.1.15\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"1Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, Korea; 2Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea; 3Institute of Radiation Medicine, Seoul National University College of Medicine, Seoul, Korea; 4School of Pharmacy, Sungkyunkwan University, Suwon, Korea; 5College of Pharmacy, Daegu Catholic University, Gyeongsan, Korea\",\"PeriodicalId\":36088,\"journal\":{\"name\":\"Journal of Radiation Protection and Research\",\"volume\":\"56 1\",\"pages\":\"\"},\"PeriodicalIF\":0.6000,\"publicationDate\":\"2019-03-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Radiation Protection and Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.14407/JRPR.2019.44.1.15\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"NUCLEAR SCIENCE & TECHNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Radiation Protection and Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14407/JRPR.2019.44.1.15","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"NUCLEAR SCIENCE & TECHNOLOGY","Score":null,"Total":0}
Psammaplin A-Modified Novel Radiosensitizers for Human Lung Cancer and Glioblastoma Cells
1Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, Korea; 2Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea; 3Institute of Radiation Medicine, Seoul National University College of Medicine, Seoul, Korea; 4School of Pharmacy, Sungkyunkwan University, Suwon, Korea; 5College of Pharmacy, Daegu Catholic University, Gyeongsan, Korea